News

Skye Bioscience Partners With Arecor: Potentially Enhanced Nimacimab Dosing
Skye’s Nimacimab shows promise in obesity treatment with lean mass preservation. Phase 2a results slated for 2025 could drive ...
Global Kratom Coalition Applauds FDA Action Against Hydroxie and Expects Broader Crackdown Against Synthetic Opioids Like 7
FDA action aligns with a growing chorus of scientists, public health experts, and advocates warning against the public health ...
The Marijuana Herald6d
Study: Minor Cannabinoids Like CBN and CBC Show Potent Anti-Cancer Effects in Breast Cancer Models
Researchers from the Universidade do Porto have identified promising anti-cancer properties in four lesser-known cannabinoids ...
EMBO Press2d
Hippo pathway controls biopterin metabolism to shield adjacent cells from ferroptosis in lung cancer
Heterogeneous Hippo pathway (YAP/TAZ) activation in lung adenocarcinoma drives tumor progression by enabling ferroptosis ...
Study uncovers key RNA-driven network behind colorectal cancer progression and immune response
A research team led by Prof. Gu Hongcang and Zhang Fan from the Hefei Institutes of Physical Science of the Chinese Academy ...
The Marijuana Herald3d
Study: THC and CBD Combination Reduces Inflammation Triggered by Viral Immune Receptors
New research published in the European Journal of Pharmacology found that THC and CBD—especially when combined in equal parts ...
C&EN15h
Mass Spectrometry-Based GPCR Proteomics: Comprehensive Characterization of the Human Cannabinoid 1 Receptor | Journal of Proteome Research - ACS Publications
The human cannabinoid 1 receptor (hCB1), a ubiquitous G protein-coupled receptor (GPCR), transmits cannabinergic signals that participate in diverse (patho)physiological processes. Pharmacotherapeutic ...
Filter23h
Study Supports Creation of Universal Cannabis Aroma and Flavor Wheel
The research also outlined how future innovations could lead to the discovery of novel aroma and flavor compounds.